Furthermore, urinary infections are not significantly higher for PTDM patients and can be managed with standard treatments. Combination therapies involving GLP-1 agonists and SGLT-2 inhibitors have shown promise in managing co-morbidities associated with liver transplant recipients
This isnt arbitraryits based on how long these medications remain active in your system and how long it takes your body to stabilize after stopping
[DOI] [PubMed] [Google Scholar] 129.Luck H., Tsai S., Chung J., Clemente-Casares X., Ghazarian M., Revelo X.S., Lei H., Luk C.T., Shi S.Y., Surendra A., et al
You should be a good candidate for treatment if you have any of these concerns, so long as you dont have any allergies or conditions that would cause a conflict
Liraglutide (Victoza, Saxenda): Also approved by the FDA for weight loss, but requires daily injections to see results
GLP-1 medications dont target belly fat specifically, but they can support overall fat loss (including visceral fat) by helping appetite control and calorie adherence